Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

VELCADE in Previously Treated Patients With Stage IIIB and IV Bronchioloalveolar Carcinoma (BAC) and Adenocarcinoma With BAC Features

This study has been terminated.
(insufficient efficacy)
Sponsor:
Information provided by:
Millennium Pharmaceuticals, Inc.
ClinicalTrials.gov Identifier:
NCT00117351
First received: June 30, 2005
Last updated: February 16, 2011
Last verified: February 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: July 2007
  Primary Completion Date: June 2007 (Final data collection date for primary outcome measure)